Fluoguide AS
STO:FLUO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Fluoguide AS
Net Income
Fluoguide AS
Net Income Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Net Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
F
|
Fluoguide AS
STO:FLUO
|
Net Income
-kr45m
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
N/A
|
|
|
Genmab A/S
CSE:GMAB
|
Net Income
kr1.2B
|
CAGR 3-Years
7%
|
CAGR 5-Years
6%
|
CAGR 10-Years
27%
|
|
|
Zealand Pharma A/S
CSE:ZEAL
|
Net Income
kr6.5B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Galecto Inc
NASDAQ:GLTO
|
Net Income
-$21.4m
|
CAGR 3-Years
25%
|
CAGR 5-Years
10%
|
CAGR 10-Years
N/A
|
|
|
Ascendis Pharma A/S
NASDAQ:ASND
|
Net Income
-€228m
|
CAGR 3-Years
27%
|
CAGR 5-Years
11%
|
CAGR 10-Years
-21%
|
|
|
B
|
Bavarian Nordic A/S
CSE:BAVA
|
Net Income
kr1.4B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
38%
|
CAGR 10-Years
37%
|
|
Fluoguide AS
Glance View
FluoGuide A/S engages in the development of surgical solutions to reduce suffering for the patient and increase the likelihood of cure; as well as reducing costs for the health care system. The firm develops surgical solutions, which expected to reduce Cancer pain for the patient and increases the possibility of recovering as well as reducing costs for the health care system. The first product is the compound FG001, which lights up the cancer and its invasive growth into the surrounding tissue.
See Also
What is Fluoguide AS's Net Income?
Net Income
-45m
DKK
Based on the financial report for Dec 31, 2025, Fluoguide AS's Net Income amounts to -45m DKK.
What is Fluoguide AS's Net Income growth rate?
Net Income CAGR 5Y
-15%
Over the last year, the Net Income growth was -30%. The average annual Net Income growth rates for Fluoguide AS have been -11% over the past three years , -15% over the past five years .
